Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1CNS 1

Conditions

Glioblastoma 80Prostatic Neoplasms 57Breast Neoplasms 54Carcinoma, Non-Small-Cell Lung 53Esophageal Neoplasms 48Rectal Neoplasms 42Lung Neoplasms 41Squamous Cell Carcinoma of Head and Neck 33Head and Neck Neoplasms 33Brain Neoplasms 33Gliosarcoma 31Pancreatic Neoplasms 29Uterine Cervical Neoplasms 28Neoplasms 25Glioma 24Neoplasm Metastasis 23Sarcoma 22Oropharyngeal Neoplasms 21Melanoma 19Esophageal Squamous Cell Carcinoma 19Astrocytoma 18Adenocarcinoma Of Esophagus 15Stomach Neoplasms 14Precursor Cell Lymphoblastic Leukemia-Lymphoma 12Carcinoma, Squamous Cell 12Urinary Bladder Neoplasms 11Mouth Neoplasms 11Lymphoma, Follicular 11Central Nervous System Neoplasms 11Carcinoma 11

Interventions

Vincristine 2Temozolomide 2Oncolytic Virotherapy 2vorasidenib 1repotrectinib 1pralsetinib 1pembrolizumab 1pamiparib 1lutetium Lu 177 dotatate 1interferon gamma-1b 1copper dotatate CU-64 1cixutumumab 1Vorinostat 1Valproic Acid 1Thiotepa 1Sunitinib 1Radiotherapy 1Radiation 1Peripheral Blood Stem Cell Transplantation 1ONC206 1Melphalan 1Maintenance Chemotherapy 1Lutetium-177 1Lutetium 1Lomustine 1Interleukin-12 1Interferon-gamma 1Immunotherapy 1Granulocyte Colony-Stimulating Factor 1Filgrastim 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Neuroectodermal Tumors × Radiation × Clear all
NCT03150862 2025-02-04

A Study Assessing Pamiparib With Radiation and/or Temozolomide (TMZ) in Participants With Newly Diagnosed or Recurrent Glioblastoma

BeiGene

Phase 1/2 Completed
116 enrolled 31 charts
CNSSarcoma

Astrocytoma, Brain Neoplasms, Glioblastoma, Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Nervous System Diseases, Central Nervous System Neoplasms, Neuroectodermal Tumors, Gliosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡